|Scientist||Papers||Citations||Citations per paper|
|1||Walter C. Willett (epidemiology) Harvard University, Boston, MA||553||28,393||51.34|
|2||Meir J. Stampfer (epidemiology) Harvard University, Boston, MA||338||24,494||72.47|
|3||Paul M. Ridker (epidemiology) Harvard University, Boston, MA||237||24,072||101.57|
|4||Salim Yusuf (cardiology) McMaster University, Hamilton, Canada||7||23,280||84.04|
|5||Daniel Levy (cardiology) NHLBI and Boston University, MA||259||22,644||87.43|
|6||Rory Collins (epidemiology) University of Oxford||141||22,596||160.26|
|7||Richard Peto (epidemiology) University of Oxford||91||20,394||224.11|
|8||Bert Vogelstein (oncology) Johns Hopkins University, Baltimore, MD||99||20,319||205.24|
|9||JoAnn E. Manson (epidemiology) Harvard University, Boston, MA||316||20,098||63.60|
|10||Eric J. Topol (cardiology) The Scripps Research Institute, La Jolla, CA||429||20,083||46.81|
For these data, 15,858 authors are listed in the field of clinical medicine, meaning that a total of approximately 1,585,800 authors’ records were reviewed to obtain these results. As the data show, large-scale clinical studies, including the use of meta-analysis, were very influential in the past decade, represented by the work of nine of the ten authors listed, several specialising in epidemiology.
Exceptional is the research of Bert Vogelstein, whose studies of the molecular genetics of colon and other cancers have had a profound influence for many years. Note also his high citations per paper score. In fact, Professor Vogelstein has long been a chief pick of Thomson Reuters for a Nobel Prize in Physiology or Medicine.
For more information on Thomson Reuters’ Essential Science Indicators, see http://scientific.thomsonreuters.com/products/esi.